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Objectives: We characterized and assessed public health measures, including
intensive vaccination and antiviral treatment, implemented during the 2009
influenza pandemic in the Republic of Korea.
Methods: A mathematical model for the 2009 influenza pandemic is formulated.
The transmission rate, the vaccination rate, the antiviral treatment rate, and the
hospitalized rate are estimated using the least-squares method for the 2009 data
of the incidence curves of the infected, vaccinated, treated, and hospitalized.
Results: The cumulative number of infected cases has reduced significantly
following the implementation of the intensive vaccination and antiviral treat-
ment. In particular, the intensive vaccination was the most critical factor that
prevented severe outbreak.
Conclusion: We have found that the total infected proportion would increase by
approximately six times under the half of vaccination rates.1. Introduction
The worldwide influenza A/H1N1 pandemic in
2009e2010 had a huge impact on the public health
system in Korea. The Korean scientists traced the
pathogenesis and chronological localization of influenza
A/H1N1 [1], and also evaluated and identified strains
with antiviral resistance in Korea [2]. Surveillance data
on influenza-like illness (ILI) were used to estimate the
number of patients with influenza in Korea [3]. Mathe-
matical models were formulated to evaluate the pa-
rameters of the existing preparedness plans in Korea [4].ted under the terms of the C
0) which permits unrestrict
roperly cited.
ase Control and PreventionMany pharmaceutical and nonpharmaceutical measures
were implemented during an epidemic to delay the peak
of the epidemic curve and reduce the casualties [5]. A
previous study had demonstrated the effectiveness of
nonpharmaceutical measures under certain situations
[6], but the timely intervention with pharmaceutical
measures using vaccines and antiviral treatment is
known to effectively contain or mitigate the impact of
an outbreak [7e9]. Public health experts have closely
monitored the preventive strategies implemented for
recurrent or future epidemics. Recently, many more
realistic, tailored mathematical transmission modelsreative Commons Attribution Non-Commercial License (http://
ed non-commercial use, distribution, and reproduction in any
. Published by Elsevier Korea LLC. All rights reserved.
48 C. Chu, S. Leehave been developed to answer specific public health
questions on an epidemic and their empirical validity
have been tested [8,9]. This study aims to investigate
how the onset time and the levels of control measures
are associated with the effectiveness of intensive
vaccination and antiviral treatment. In this study, results
from models with full-control measures and models with
partial control measures were compared, highlighting
the significant differences in model outcomes.2. Materials and methods
A mathematical influenza transmission model was
proposed to investigate the characteristic of the 20098>>>>><
>>>>>>:
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Z bSðtÞ½fbAðtÞ þ IðtÞg=NðtÞ  uðtÞSt
_VðtÞZuðtÞSðtÞ  1 sbVtðfbAðtÞ þ IðtÞgÞ=Nt
_EðtÞZfSðtÞ þ ð1 sÞVðtÞgb½fbAðtÞ þ IðtÞg=Nt kEt
_IðtÞZkpEðtÞ  ðaþ gþ f ÞIt
_AðtÞZkð1 pÞEðtÞ  gAt
_HðtÞZaIðtÞ  ðqþ dÞHt
_RðtÞZg½AðtÞ þ IðtÞ þ fItþ qHt
_DðtÞZdHtinfluenza pandemic and to evaluate the impact of
intensive vaccination and antiviral treatment methods
implemented in the Republic of Korea. A standard
compartment model was used to divide the population
into eight compartments with different epidemiological
status. The Korean population is integrated to the
influenza transmission model, based on data from the
2009 census. Our model classifies individuals as sus-
ceptible (S ), vaccinated (V), exposed (E ), clinically ill
and infectious (I ), asymptomatic but still infectious (A),
hospitalized (H ), recovered (R), and dead (D). It is
assumed that susceptible individuals become infected at
rate:
b
bAðtÞ þ IðtÞ
NðtÞ
where the total population size is given as follows:
NðtÞZSðtÞ þVðtÞ þEðtÞ þ IðtÞ þAðtÞ þHðtÞ þRðtÞ
Vaccination is administered to susceptible in-
dividuals with a vaccination rate u(t). We assumed that
the vaccine provides only partial immunity so that
vaccinated individuals are less susceptible than unvac-
cinated individuals, which is modeled by vaccine effi-
cacy (s). Latently infected individuals proceed to
become infectious with a latent period, 1=k and a
proportion (p) of infected individuals becomesymptomatic. We define b as relative infectiousness of
asymptomatic cases compared with symptomatic cases.
Both symptomatic and asymptomatic individuals
recover at the rate g. Infectious individuals are treated
with an antiviral drug at the rate f. Infectious individuals
are hospitalized at the rate a and recover at the rate g.
Hospitalized individuals either recover at the rate q or
die from influenza at the rate d. Recovered individuals
are assumed to remain protected for the duration of the
epidemic. The baseline values of epidemiological pa-
rameters are presented in Table 1. The population is
assumed to be completely susceptible at the beginning
of the epidemic. The system of differential equations
that describes our influenza transmission model is given
as follows:Moreover, the basic reproductive number for the
aforementioned system is written as:
R0Zb

p
g
þ ð1 pÞb
g
3. Results
Simulation results are generated by numerically
solving the given influenza dynamical system. Param-
eter estimations were carried out using the incidence
data of clinically infected, vaccinated, treated, and
hospitalized patients during the 2009 influenza
pandemic in the Republic of Korea. First, the trans-
mission rate, the vaccination rate, the antiviral treatment
rate, and the hospitalized rate were estimated using the
least-squares method for the 2009 influenza data,
respectively. The estimated range R0 for the 2009
influenza pandemic is approximately 1.5 using the
transmission rate b in Table 1, and the expression for the
basic reproductive number R0 is presented earlier. The
estimated vaccination, antiviral treatment, and hospi-
talized rates are presented in Table 1 and shown in
Figure 1E. Next, we explored a baseline pandemic
scenario in the context of the 2009 A/H1N1 outbreak in
Table 1. Baseline parameter values calibrated from the 2009 influenza pandemic in the Korea.
Parameter Description Value Reference
b Transmission rate (days1) 0.8 Data fitted
u Vaccination rate (days1) 0e0.006 Data fitted
f Antiviral treatment rate (days1) 0e0.6 Data fitted
A Diagnostic rate (days1) 0e0.08 Data fitted
s Vaccine efficacy 0.8 Korea Centers for Disease
Control and Prevention
b Relative infectiousness of asymptomatic cases 0.142 Lee et al [18]
p Proportion of infected individuals who become symptomatic 0.33 Lee et al [18]
k Rate of progression from the latent to infected (days1) 0.833 Lee et al [18]
g Recovery rate for infectious class (days1) 0.22 Lee et al [18]
q Recovery rate for hospitalized individuals (days1) 0.34 Lee et al [18]
Figure 1. Comparisons of the 2009 influenza data and the model output R0Z1:5.
Table 2. Comparisons of the 2009 influenza data and
model output.
Total proportion
in population
Full
intervention
scenario
Half
intervention
scenario Data
Infected 0.0200 0.1347 0.0157
Vaccinated 0.1675 0.0820 0.1690
Treatment 0.0079 0.0183 0.0102
Hospitalized 0.0015 0.0032 0.0018
Assessment of Korean vaccination system 49the Republic of Korea in the presence of these estimated
vaccination and antiviral treatments. Figure 1 illustrates
the incidence curves of the model output (solid curves)
and the incidence data (gray bars) for the infected
(Figure 1A), vaccinated (Figure 1B), treated
(Figure 1C), and hospitalized (Figure 1D) individuals.
As shown in Figure 1, the peak size and time and
epidemic duration gave a good agreement between the
model output and the data. In addition, Table 2 presents
the comparisons of the data and model output of the
total proportion of infected, vaccinated, treated, and
hospitalized patients.
50 C. Chu, S. LeeWe evaluated the impact of these intensive vaccina-
tion and antiviral treatments on the dynamics of influ-
enza pandemics by comparing the results using the full
interventions and the ones under less than half of
vaccination and antiviral treatment coverage. The inci-
dence curves of infected patients under the full in-
terventions (solid curve) and the less than half
interventions (broken curve) are shown in Figure 1F. It
is worth noting that the total proportion of infected in-
dividuals had significantly increased from 0.02
to 0.1347 in Table 2. Particularly, the intensive vacci-
nation was found to be the most critical factor that
prevents severe outbreak. We also found that the total
infected proportion would increase by approximately six
times under the half of vaccination rates.4. Discussion
Previous studies have focused on the effectiveness of
a timely introduction of vaccination to reduce the peak
of the epidemic curve and delay the epidemic curve
[9e13]. In a study that evaluated the effect of vacci-
nation in Korean military camps, the H1N1pdm09
vaccine, administered in January 2010, had approxi-
mately 50% effectiveness against the H1N1pdm09
outbreak that occurred in December 2010. The magni-
tude of vaccination effectiveness was robust with no
substantial difference, even when multivariate analysis
and various ILI definitions were used. The magnitude of
vaccine effectiveness was <70% effectiveness achieved
during the 2009e2010 H1N1pdm09 season in previous
studies, but the rate was similar to the effectiveness
achieved during the 2010e2011 season. Studies that
evaluated the vaccination effectiveness 1 year after a
vaccination program have indicated that the vaccination
effectiveness was not persistent because there were no
statistically significant results [14]. However, it was
shown that there was still statistically significant
vaccination effectiveness 1 year after the vaccination.
This was immunologically consistent with the results of
an existing antigenicity study in which the vaccination
effectiveness was persistent 1 year after the seasonal
influenza vaccination, although the antibody titer
decreased [15]. Previous studies have evaluated antiviral
treatment and showed its limitation in public health
measures [16e18].
Simulation results show that the full intervention
scenario showed rates close to the 2009 influenza data in
the total infected proportion, vaccinated proportion,
treatment proportion, and hospitalized proportion in
Table 2. This shows that the 2009 pandemic counter-
measures in Korea had an excellent effectiveness. The
estimated vaccination, antiviral treatment, and hospi-
talized rates are presented in Table 1 and shown in
Figure 1F. Four curves (AeC, and E) in Figure 1 had a
fair match with real data with the exception of thehospitalization proportion (Figure 1D). This can be
interpreted as follows: with the introduction of mass
vaccination in early September, the patients were more
likely treated at their homes. Figure 1E shows the rates
of vaccination, antiviral treatment, and hospitalization.
The curves simply show the rate of each category. It is
different from those numbers presented in Table 2 in
that the proportions presented are total proportions of
the population, whereas each curve in Figure 1 shows
the rate of time-dependent function in the differential
equations in our model.
We evaluated the impact of these intensive vaccina-
tion and antiviral treatments on the dynamics of influ-
enza pandemics by comparing the results under the full
interventions scenario and the ones under less than half
of vaccination and antiviral treatment coverage in
Figure 1F. The difference is not huge between full
intervention and real data in each proportion presented
in Table 2. Surprisingly enough, the proportion of
infected persons in real data (0.1257) is less than that of
the full intervention scenario (0.02). This might warrant
some discussion, but it is worthwhile to give full credit
to Korean public health workers for their efforts during
the 2009e2010 influenza pandemic. Lastly, the inten-
sive vaccination was the single most critical factor that
prevents a severe outbreak. We have found that the total
infected proportion would increase by approximately six
times under the half of vaccination rates.
This study has shown a unique approach to evaluate
the effectiveness of mass vaccination in Korea. This
evaluation would provide a valuable insight for public
health officials and scientists to prepare for the next
possible pandemic in Korea.Conflicts of interest
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